The yield of a comprehensive investigation protocol for the diagnosis of true idiopathic ventricular fibrillation in a real-life clinical setting.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 Jun 2024
Historique:
received: 26 10 2023
accepted: 10 06 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 18 6 2024
Statut: epublish

Résumé

Traditionally, aborted cardiac arrest (ACA) due to documented ventricular fibrillation (VF) in the absence of structural heart disease has been termed idiopathic VF. By careful evaluation, a specific etiology can be found in a substantial proportion of patients. The aim of this survey was to assess the yield of an advanced diagnostic work-up to reveal a causative etiology in a real-life clinical setting. Patients from the University Hospital Brno's ACA database were analyzed (514 patients in total). Forty-six patients (31 males) fulfilled the inclusion criteria, which were: (1) absence of structural pathology on echocardiography; (2) absence of coronary artery disease; and (3) absence of reversible cause of ACA. The diagnostic work-up consisted in cardiac magnetic resonance imaging, stress testing, sodium channel blocker challenge, and genetic testing according to the availability of the method and patient compliance. A specific disease was found in 17 individuals (37.0%), although at least one diagnostic step was refused by 13 patients (28.3%). True idiopathic VF was confirmed in 7 patients (15.2%), for whom the entire diagnostic work-up did not reveal any specific pathology. Our real-life survey shows that, even with an incomplete diagnostic work-up (due to the unavailability of a particular method or variable patient compliance), a specific diagnosis can be identified in more than one third of the cases of "idiopathic" VF, which can thus enable targeted treatment and family screening.

Identifiants

pubmed: 38890420
doi: 10.1038/s41598-024-64513-7
pii: 10.1038/s41598-024-64513-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14089

Subventions

Organisme : Ministry of Health of the Czech Republic
ID : NU22-02-00348
Organisme : Ministry of Health of the Czech Republic - DRO
ID : FNBr. 65269705

Informations de copyright

© 2024. The Author(s).

Références

Priori, S. G. et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur. Heart J. 36, 2793–2867 (2015).
doi: 10.1093/eurheartj/ehv316 pubmed: 26320108
Winkel, B. G. et al. Nationwide study of sudden cardiac death in persons aged 1–35 years. Eur. Heart J. 32, 983–990 (2011).
doi: 10.1093/eurheartj/ehq428 pubmed: 21131293
Pilmer, C. M., Kirsh, J. A., Hildebrandt, D., Krahn, A. D. & Gow, R. M. Sudden cardiac death in children and adolescents between 1 and 19 years of age. Heart Rhythm 11, 239–245 (2014).
doi: 10.1016/j.hrthm.2013.11.006 pubmed: 24239636
Risgaard, B. et al. Burden of sudden cardiac death in persons aged 1 to 49 years: Nationwide study in Denmark. Circ. Arrhythm. Electrophysiol. 7, 205–211 (2014).
doi: 10.1161/CIRCEP.113.001421 pubmed: 24604905
Waldmann, V. et al. Burden of coronary artery disease as a cause of sudden cardiac arrest in the young. J. Am. Coll. Cardiol. 73, 2118–2120 (2019).
doi: 10.1016/j.jacc.2019.01.064 pubmed: 31023437
Waldmann, V. et al. Low rates of immediate coronary angiography among young adults resuscitated from sudden cardiac arrest. Resuscitation 147, 34–42 (2020).
doi: 10.1016/j.resuscitation.2019.12.005 pubmed: 31857140
Bagnall, R. D. et al. A prospective study of sudden cardiac death among children and young adults. N. Engl. J. Med. 374, 2441–2452 (2016).
doi: 10.1056/NEJMoa1510687 pubmed: 27332903
Winkel, B. G. et al. Sudden cardiac death in children (1–18 years): Symptoms and causes of death in a nationwide setting. Eur. Heart J. 35, 868–875 (2014).
doi: 10.1093/eurheartj/eht509 pubmed: 24344190
Visser, M. et al. Idiopathic ventricular fibrillation: The struggle for definition, diagnosis, and follow-up. Circ. Arrhythm. Electrophysiol. 9, e003817. https://doi.org/10.1161/CIRCEP.115.003817 (2016).
doi: 10.1161/CIRCEP.115.003817 pubmed: 27103090
Zeppenfeld, K. et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur. Heart J. https://doi.org/10.1093/eurheartj/ehac262 (2022).
doi: 10.1093/eurheartj/ehac262 pubmed: 36017572 pmcid: 9392651
Wilde, A. A. M. et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. EP Eur. 24, 1307–1367 (2022).
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
doi: 10.1038/gim.2015.30 pubmed: 25741868 pmcid: 4544753
Meissner, M. D. et al. Ventricular fibrillation in patients without significant structural heart disease: A multicenter experience with implantable cardioverter-defibrillator therapy. J. Am. Coll. Cardiol. 21, 1406–1412 (1993).
doi: 10.1016/0735-1097(93)90317-T pubmed: 8473649
Krahn, A. D. et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac arrest survivors with preserved ejection fraction registry (CASPER). Circulation 120, 278–285 (2009).
doi: 10.1161/CIRCULATIONAHA.109.853143 pubmed: 19597050
van der Werf, C. & Wilde, A. A. M. Why did this patient experience a sudden cardiac arrest? Follow your curiosity!. Heart Rhythm 16, 1240–1241 (2019).
doi: 10.1016/j.hrthm.2019.02.028 pubmed: 30818094
Corrado, D. et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int. J. Cardiol. 319, 106–114 (2020).
doi: 10.1016/j.ijcard.2020.06.005 pubmed: 32561223
Zaman, A. et al. Role of cardiac MRI imaging of focal and diffuse inflammation and fibrosis in cardiomyopathy patients who have pacemakers/ICD devices. Curr. Cardiol. Rep. 24, 1529–1536 (2022).
doi: 10.1007/s11886-022-01770-w pubmed: 35984554 pmcid: 10123953
Giudicessi, J. R. & Ackerman, M. J. Exercise testing oversights underlie missed and delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia in young sudden cardiac arrest survivors. Heart Rhythm 16, 1232–1239 (2019).
doi: 10.1016/j.hrthm.2019.02.012 pubmed: 30763784
Andrsova, I. et al. Clinical characteristics of 30 Czech families with long QT syndrome and KCNQ1 and KCNH2 gene mutations: Importance of exercise testing. J. Electrocardiol. 45, 746–751 (2012).
doi: 10.1016/j.jelectrocard.2012.05.004 pubmed: 22727609
Andrsova, I. et al. Clinical characteristics and mutational analysis of the RyR2 gene in seven Czech families with catecholaminergic polymorphic ventricular tachycardia. Pacing Clin. Electrophysiol. 35, 798–803 (2012).
doi: 10.1111/j.1540-8159.2012.03399.x pubmed: 22519458
Waldmann, V. et al. Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: Focus on idiopathic ventricular fibrillation. Eur. Heart J. 39, 1981–1987 (2018).
doi: 10.1093/eurheartj/ehy098 pubmed: 29566157 pmcid: 5982722
Synková, I. et al. Long-QT founder variant T309I-Kv7.1 with dominant negative pattern may predispose delayed afterdepolarizations under β-adrenergic stimulation. Sci. Rep. 11, 3573. https://doi.org/10.1038/s41598-021-81670-1 (2021).
doi: 10.1038/s41598-021-81670-1 pubmed: 33574382 pmcid: 7878757

Auteurs

Samuel Lietava (S)

Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Milan Sepsi (M)

Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic. sepsi.milan@fnbrno.cz.

Jana Zidkova (J)

Centre of Molecular Biology and Genetics, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Iva Synkova (I)

Centre of Molecular Biology and Genetics, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Milan Kozak (M)

Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Lubomir Krivan (L)

Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Jitka Vlasinova (J)

Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Svatopluk Richter (S)

Department of Radiology and Nuclear Medicine, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Jan Rehor (J)

Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Petr Kala (P)

Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Marketa Bebarova (M)

Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.

Tomas Novotny (T)

Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH